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EDITORIAL
Dear colleagues,
In this issue of our journal we invited a team from the field of paediatric endocrinology, led by Hadjieva 
et al. to review morbidity and mortality in long-term type 1 diabetes. Type 1 diabetes (T1D) is one of the most 
frequent chronic diseases in children and its incidence has been increasing worldwide in recent decades. Its 
prevalence varies with geographic and ethnic differences, but universally accounts for as much as 90% of chil-
dren and adolescents with diabetes, and 5 to 10% of adults with diabetes (1). As many as over 95,000 youths get 
type 1 diabetes mellitus annually. Despite advances in diabetes care and management, the disease is still as-
sociated with increased morbidity and premature mortality. The cardiovascular (CV) diseases are recognized 
as one of the leading causes of the excess death in T1D population. Diabetes per se is characterized by an in-
creasing risk of complications, and recent studies highlight the specific difference in CV risk predicting fac-
tors according to the diabetes duration (2) and metabolic control and renal disease (3). Among the intriguing 
CV risk factors, the trend of increasing obesity prevalence in general and also among people with T1D is at-
tracting more and more attention.
The submitted review has the advantage of focusing on mortality rates and causes of death among adults 
with childhood-onset T1D populations from different latitudes with different disease incidence. Furthermore, 
it reports how disease duration, age at diagnosis, and year of diagnosis affect the mortality trends. It is note-
worthy that premature mortality is still present even in societies with well-organized health care systems and 
unrestricted access to treatment of the disease. More evidence is accumulated about the possible prevention 
or at least postponing of CV complications and adverse outcomes by timely introduction of measures such as 
decreasing of hyperlipidemia, non-smoking and other traditional CV risk factors (4). This emphasizes an ur-
gent need for efforts towards prevention of long-term diabetes complications especially CV and renal diseases, 
being the predominant causes of mortality nowadays. The current contemporary review summarizes the ac-
cumulated knowledge in the field and elucidates the need for studies that could lead to a successful preventive 
strategy. 
Enjoy reading!
Prof. Christina Grupcheva, MD, PhD, DSc, FEBO, FICO(Hon), FBCLA, FIACLE
Co-Editor-in-Chief
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